Posts
Military Metals License Cancellation
Ticker: MILI.CN / MILIF Category: Mining / Antimony I rarely find people talking about this stock, so I wanted to bring up a discussion regarding the massive drop yesterday following the Slovakian government’s abrupt cancellation of their exploration license over "unspecified reasons." For context: Their flagship mine, Trojarova, is considered …
HUBC IS ON FIRE
I've been digging into HUBC (HUB Cyber Security) and think it deserves a closer look from investors who follow high-risk, high-reward turnaround and squeeze candidates. A few things that stand out: • Cybersecurity sector exposure with focus on secure data infrastructure and confidential computing. • Very small market capitalization relative …
$OLB at ~$0.49 – AI Pivot + PayPal Partnership While Super Cheap?
$OLB is currently trading around $0.49, near multi-year lows with a market cap under $7M. The company has been making some meaningful moves lately: • Strategic pivot to AI-Driven OmniCommerce • Global PayPal partnership announced earlier this year • Significant cost reductions and a strengthened balance sheet in 2025 • …
RXRX - Squeeze imminent, huge SI and massive call buying
Been looking at RXRX again and I think it’s one of the cleaner “AI application” plays if money starts rotating out of pure AI hardware / semis and into companies actually using AI in a vertical with proprietary data. Not trying to make this sound like some guaranteed squeeze. It’s …
$GLMD or $PRFX — which setup are you watching?
$PRFX had the big after-hours spike. Meanwhile $GLMD has been grinding higher the last couple sessions and is now sitting around $0.71. Quick technical thoughts on $GLMD if it breaks from here: • Currently hovering just above the $0.68–$0.70 area after back-to-back green days • If it can clear $0.75–$0.80 …
BDTX looks worth keeping on the watchlist heading into ASCO.
Black Diamond Therapeutics recently reported positive Phase 2 data for **silevertinib**, its brain-penetrant EGFR inhibitor for frontline NSCLC patients with **EGFR non-classical mutations**. High-level results from the May update: * **Preliminary median PFS: 15.2 months** * **Median DOR not reached** * **60% ORR** * **91% disease control rate** * **86% …
29 may , what are the biggest losers Pre-market ?
# Top Losers (Biggest Losers) |Rank|Ticker|% Change|Price|Volume|Why / Notes| |:-|:-|:-|:-|:-|:-| |1|**ZCMD**|**-65.14%**|$0.54|\~2M|Sharp drop, possibly post-rally profit taking or bad news.| |2|**SUGP**|**-44.09%**|$1.49|\~2.2M|Heavy selling pressure.| |3|**PLAB**|**-36.42%**|$34.02|10.5M|Significant decline on higher volume (more established company).| |4|**AMSS**|**-25.44%**|$4.25|\~900K|Continuation of weakness.| |5|**HDRN**|**-24.75%**|$3.01|\~500K|Down sharply.| Other losers: **PNRG** (-23.89%), **WCT**, **GMM**.
29 may 2026 , what are the biggest winners Pre-market
|Rank|Ticker|% Change|Price|Volume|Why / Notes| |:-|:-|:-|:-|:-|:-| |1|**MASK**|**+199.28%**|$4.13|149M+|Massive surge, likely news, short squeeze, or hype. Extremely high volume.| |2|**CGTL**|**+151.49%**|$0.70|119M+|Huge retail momentum play. Very low-priced stock with explosive volume.| |3|**SPRC**|**+140.32%**|$10.55|35M+|Strong buying interest, possibly sector/news driven.| |4|**ASTC**|**+113.11%**|$29.43|48M+|Major move (space/tech related themes active lately).| |5|**ATPC**|**+112.98%**|$6.07|54M+|Another low-float/high-momentum name.|
Bullish case for $CXAI
$CXAI bull case is relatively straightforward: tiny valuation, real enterprise AI software, and a market still pricing the company like execution will fail. Recent quarterly revenue was only around $950K, but the more interesting metrics were: \~98% subscription revenue \~83% gross margins \~$1.4M bookings and over $5M in new multi-year …
RXRX Continuation: Yesterday Hit $3.50 — Now I’m Watching the Failed-Squeeze Retrace
🐻 **Bearish / cautious short-term** 🐻 Ticker: **RXRX** Company: **Recursion Pharmaceuticals** Current setup: **failed-squeeze / retrace watch** Bias: **bearish short-term unless bulls reclaim strength** Key breakdown area: **$3.10 / $3.00** Primary downside target: **$2.87–$2.80** Stretch target: **$2.60** Invalidation: **reclaim and hold above $3.35–$3.50** Yesterday was a bloodbath for early shorts. …